{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T18:20:02Z","timestamp":1771266002996,"version":"3.50.1"},"reference-count":16,"publisher":"Japan Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2013]]},"DOI":"10.1507\/endocrj.ej12-0283","type":"journal-article","created":{"date-parts":[[2012,10,12]],"date-time":"2012-10-12T23:22:09Z","timestamp":1350084129000},"page":"167-172","source":"Crossref","is-referenced-by-count":22,"title":["Efficacy of a combined alendronate and calcitriol agent (Maxmarvil&lt;sup&gt;\u00ae&lt;\/sup&gt;) in Korean postmenopausal women with early breast cancer receiving aromatase inhibitor: a double-blind, randomized, placebo-controlled study"],"prefix":"10.1507","volume":"60","author":[{"given":"Yumie","family":"Rhee","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Endocrine Research Institute, and Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, 120-752, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kijun","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Yonsei University College of Medicine, 120-752, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seho","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Surgery, Yonsei University College of Medicine, 120-752, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyung Seok","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Surgery, Yonsei University College of Medicine, 120-752, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Kil","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Endocrine Research Institute, and Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, 120-752, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byeong Woo","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Surgery, Yonsei University College of Medicine, 120-752, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.08.8617"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Forbes JF, Cuzick J, Buzdar A, Howell A, Tobias JS, Baum M (2008) Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial. <i>Lancet Oncol<\/i> 9:45-53.","DOI":"10.1016\/S1470-2045(07)70385-6"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Buzdar A, Chlebowski R, Cuzick J, Duffy S, Forbes J, <i>et al.<\/i> (2006) Defining the role of aromatase inhibitors in the adjuvant endocrine treatment of early breast cancer. <i>Curr Med Res Opin<\/i> 22:1575-1585.","DOI":"10.1185\/030079906X120940"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199809103391104"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Reid DM, Doughty J, Eastell R, Heys SD, Howell A, <i>et al.<\/i> (2008) Guidance for the management of breast cancer treatment-induced bone loss: a consensus position statement from a UK Expert Group. <i>Cancer Treat Rev<\/i> 34 Suppl 1:S3-18.","DOI":"10.1016\/j.ctrv.2008.03.007"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Brufsky A, Bundred N, Coleman R, Lambert-Falls R, Mena R, <i>et al.<\/i> (2008) Integrated analysis of zoledronic acid for prevention of aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole. <i>Oncologist<\/i> 13:503-514.","DOI":"10.1634\/theoncologist.2007-0206"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Bundred NJ, Campbell ID, Davidson N, DeBoer RH, Eidtmann H, <i>et al.<\/i> (2008) Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: ZO-FAST Study results. <i>Cancer<\/i> 112:1001-1010.","DOI":"10.1002\/cncr.23259"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.24.5902"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Lester JE, Dodwell D, Purohit OP, Gutcher SA, Ellis SP, <i>et al.<\/i> (2008) Prevention of anastrozole-induced bone loss with monthly oral ibandronate during adjuvant aromatase inhibitor therapy for breast cancer. <i>Clin Cancer Res<\/i> 14:6336-6342.","DOI":"10.1158\/1078-0432.CCR-07-5101"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Swami S, Krishnan AV, Wang JY, Jensen K, Peng L, <i>et al.<\/i> (2011) Inhibitory Effects of Calcitriol on the Growth of MCF-7 Breast Cancer Xenografts in Nude Mice: Selective Modulation of Aromatase Expression in vivo. <i>Horm Cancer<\/i> 2:190-202.","DOI":"10.1007\/s12672-011-0073-7"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1210\/en.2009-0855"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-006-0200-4"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.3322\/caac.20103"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-008-0518-8"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.0707onj"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Shane E, Burr D, Ebeling PR, Abrahamsen B, Adler RA, <i>et al.<\/i> (2010) Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. <i>J Bone Miner Res<\/i> 25:2267-2294.","DOI":"10.1002\/jbmr.253"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/60\/2\/60_EJ12-0283\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T06:34:02Z","timestamp":1618295642000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/60\/2\/60_EJ12-0283\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej12-0283","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}